AgeX Therapeutics logo
AgeX Therapeutics AGE
$ 11.3 -10.17%

Quarterly report 2024-Q3
added 11-12-2024

report update icon

AgeX Therapeutics Cash Conversion Cycle 2011-2024 | AGE

Annual Cash Conversion Cycle AgeX Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-8.96 K -10.5 K -8.72 K -8.22 K -1.9 K -1.13 K - -246 - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-246 -10.5 K -5.67 K

Quarterly Cash Conversion Cycle AgeX Therapeutics

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- - - - -2.21 K -11 K -58.2 K - -4.61 K -4.99 K -31.4 K - -15.1 K -2.92 K -16.9 K - -3.65 K -22.5 K -53.5 K - -702 -636 -355 - 3.45 K -148 -48.8 - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
3.45 K -58.2 K -12.5 K